Indian pharmaceutical giant Wockhardt is exploring a sale. The company, known for its extensive portfolio of generic and branded pharmaceuticals, has been facing headwinds in recent quarters. Sources close to the transaction suggest that Wockhardt is {attracting interest from|receiving bids from both domestic and international firms. A final decisi